Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADC Therapeutics
Fierce Biotech
ADC Therapeutics shutters UK R&D site, lays off 30% of staff
The company is closing a U.K. R&D facility and laying off a third of its global workforce, an effort that is expected to be complete by Sept. 30.
Gabrielle Masson
Jun 12, 2025 3:00pm
MilliporeSigma's production push rolls with $76M ADC investment
Oct 29, 2024 10:33am
Piramal to pump $80M into expansion of Kentucky injectables site
Oct 1, 2024 8:12am
ADC touts early Zynlonta results in marginal zone lymphoma
May 6, 2024 4:19pm
Samsung Biologics, LegoChem link to propel ADC development
Feb 7, 2024 10:16am
Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia
Sep 1, 2023 8:50am
